Matthew C Kapusta - Net Worth and Insider Trading
Matthew C Kapusta Net Worth
The estimated net worth of Matthew C Kapusta is at least $2 Million dollars as of 2024-03-29. Matthew C Kapusta is the CEO, Managing Director of uniQure NV and owns about 440,839 shares of uniQure NV (QURE) stock worth over $2 Million. Matthew C Kapusta is also the SVP, Business Development of AngioDynamics Inc and owns about 27,005 shares of AngioDynamics Inc (ANGO) stock worth over $158,654. Details can be seen in Matthew C Kapusta's Latest Holdings Summary section.
Disclaimer: The insider information is derived from SEC filings. The estimated net worth is based on the assumption that Matthew C Kapusta has not made any transactions after 2024-02-26 and currently still holds the listed stock(s).
Transaction Summary of Matthew C Kapusta
Matthew C Kapusta Insider Ownership Reports
Based on ownership reports from SEC filings, as the reporting owner, Matthew C Kapusta owns 3 companies in total, including uniQure NV () , AngioDynamics Inc () , and Decibel Therapeutics Inc () .
Click here to see the complete history of Matthew C Kapusta’s form 4 insider trades.
Insider Ownership Summary of Matthew C Kapusta
Ticker | Comapny | Transaction Date | Type of Owner |
---|---|---|---|
uniQure NV | 2024-02-26 | director & CEO & Managing Director | |
AngioDynamics Inc | 2014-04-14 | SVP & Business Development | |
Decibel Therapeutics Inc | 2023-03-19 | director |
Matthew C Kapusta Latest Holdings Summary
Matthew C Kapusta currently owns a total of 2 stocks. Among these stocks, Matthew C Kapusta owns 440,839 shares of uniQure NV (QURE) as of February 26, 2024, with a value of $2 Million and a weighting of 93.53%. Matthew C Kapusta also owns 27,005 shares of AngioDynamics Inc (ANGO) as of April 14, 2014, with a value of $158,654 and a weighting of 6.47%.
Latest Holdings of Matthew C Kapusta
Ticker | Comapny | Latest Transaction Date | Shares Owned | Current Price ($) | Current Value ($) |
---|---|---|---|---|---|
QURE | uniQure NV | 2024-02-26 | 440,839 | 5.20 | 2,292,363 |
ANGO | AngioDynamics Inc | 2014-04-14 | 27,005 | 5.88 | 158,654 |
Holding Weightings of Matthew C Kapusta
Matthew C Kapusta Form 4 Trading Tracker
According to the SEC Form 4 filings, Matthew C Kapusta has made a total of 38 transactions in uniQure NV (QURE) over the past 5 years, including 0 buys and 38 sells. The most-recent trade in uniQure NV is the sale of 27,904 shares on February 26, 2024, which brought Matthew C Kapusta around $177,190.
According to the SEC Form 4 filings, Matthew C Kapusta has made a total of 0 transactions in AngioDynamics Inc (ANGO) over the past 5 years. The most-recent trade in AngioDynamics Inc is the acquisition of 1,000 shares on April 14, 2014, which cost Matthew C Kapusta around $13,900.
Insider Trading History of Matthew C Kapusta
- 1
Matthew C Kapusta Trading Performance
GuruFocus tracks the stock performance after each of Matthew C Kapusta's buying transactions within different timeframes. To be detailed, the average return of stocks after 3 months bought by Matthew C Kapusta is 3.35%. GuruFocus also compares Matthew C Kapusta's trading performance to market benchmark return within the same time period. The performance of stocks bought by Matthew C Kapusta within 3 months outperforms 1 times out of 2 transactions in total compared to the return of S&P 500 within the same period.
You can select different timeframes to see how Matthew C Kapusta's insider trading performs compared to the benchmark.
Performance of Matthew C Kapusta
Average Relative Return
4.32%
Outperforming Transactions
50%
1 Month | 3 Months | 6 Months | 1 Year | 2 Years | 3 Years | |
---|---|---|---|---|---|---|
Relative Return(%) | 2.07 | 3.35 | 5.07 | 4.32 | 3.35 | 7.74 |
Relative Return to S&P 500(%) | 0.51 | -0.02 | 1.07 | -11.36 | -8.07 | -4.27 |
Matthew C Kapusta Ownership Network
Ownership Network List of Matthew C Kapusta
Ownership Network Relation of Matthew C Kapusta
Matthew C Kapusta Owned Company Details
What does uniQure NV do?
Who are the key executives at uniQure NV?
Matthew C Kapusta is the director & CEO & Managing Director of uniQure NV. Other key executives at uniQure NV include Chief Financial Officer Christian Klemt , Chief Operating Officer Pierre Caloz , and Chief Medical Officer Walid Abi-saab .
uniQure NV () Insider Trades Summary
Over the past 18 months, Matthew C Kapusta made 3 insider transaction in uniQure NV () with a net sale of 37,073. Other recent insider transactions involving uniQure NV () include a net sale of 31,423 shares made by Pierre Caloz , a net sale of 21,275 shares made by Paula Soteropoulos , and a net sale of 21,087 shares made by Christian Klemt .
In summary, during the past 3 months, insiders sold 53,265 shares of uniQure NV () in total and bought 0 shares, with a net sale of 53,265 shares. During the past 18 months, 140,026 shares of uniQure NV () were sold and 0 shares were bought by its insiders, resulting in a net sale of 140,026 shares.
uniQure NV ()'s detailed insider trading history can be found in Insider Trading Tracker table.
uniQure NV Insider Transactions
Matthew C Kapusta Mailing Address
Above is the net worth, insider trading, and ownership report for Matthew C Kapusta. You might contact Matthew C Kapusta via mailing address: 7358 Mcvay Road, Germantown Tn 38138.